LSA
BLUE

L & S Advisors’s bluebird bio BLUE Stock Holding History

L & S Advisors’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-633
Closed -$753K – 307
2019
Q3 		$753K Buy
633
+6
+1% +$9.16K 0.11% 204
2019
Q2 		$1.03M Buy
627
+33
+6% +$57.1K 0.14% 166
2019
Q1 		$1.21M Buy
594
+243
+69% +$428K 0.16% 144
2018
Q4 		$452K Sell
351
-176
-33% -$270K 0.08% 200
2018
Q3 		$996K Sell
527
-302
-36% -$624K 0.13% 143
2018
Q2 		$1.68M Buy
829
+468
+130% +$1.07M 0.28% 91
2018
Q1 		$799K Buy
361
+17
+5% +$43.2K 0.15% 146
2017
Q4 		$794K Buy
+344
New +$698K 0.12% 147

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

L & S Advisors's BLUE Position: Q4 2019 in Review

L & S Advisors sold out of bluebird bio (BLUE) in Q4 2019, closing a stake of 633 shares — an estimated $753K sold.

L & S Advisors first reported a position in BLUE in Q4 2017 and held it in 8 quarters. The position peaked at $1.68M in Q2 2018. 274 funds tracked by Wall St. Rank hold BLUE as of Q4 2019.

  • L & S Advisors reported no remaining bluebird bio position as of Q4 2019 after selling out during the quarter.
  • L & S Advisors sold 633 bluebird bio shares in Q4 2019, an estimated $753K.
  • L & S Advisors first reported a position in bluebird bio in Q4 2017 and held it in 8 quarters.
  • L & S Advisors's bluebird bio position peaked at $1.68M in Q2 2018.
  • 274 funds tracked by Wall St. Rank held bluebird bio as of Q4 2019.

Based on L & S Advisors's 13F filing for Q4 2019, filed 13 Feb 2020.